OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer exercised or converted 8,895 UTHR derivative securities | OQRO

Home
Insider trades
United Therapeutics
Officer exercised or converted 8,895 UTHR derivative securities

Insider trades

Insider trade

Officer exercised or converted 8,895 UTHR derivative securities

Traded Mar 15, 2026 · Filed Mar 18, 2026

UTHUnited TherapeuticsUTHR

8,895
Shares

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 15, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 18, 2026

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001231589-26-000007

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Mar 18, 2026, 1:09 AM UTC

Added to OQRO

Oct 6, 2026, 9:34 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

UNITED THERAPEUTICS Corp

Issuer CIK

1082554

Ticker

UTHR

Reporting person

Paul A Mahon

Relationship

Officer

Officer title

EVP & GENERAL COUNSEL

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Mar 15, 2026

Transaction code

Shares / units

8,895

Acquired / disposed

Acquired (A)

Shares owned after

45,739

Ownership form

Direct

Amendment

Footnotes from the filing

Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

Around the same time

Martine A Rothblatt (Chairperson & CEO) sold ~$40K of United Therapeutics

Automatic saleFiled 6mo ago

Martine A RothblattChairperson & CEO

Filed 6mo ago

9,500Shares · @ $146.03

Traded Apr 14 · filed 3 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

Martine A Rothblatt (Chairperson & CEO) sold ~$161K of United Therapeutics

Scheduled in advanceFiled 6mo ago